We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Electronic Submissions Encouraged for Orphan Drugs
Electronic Submissions Encouraged for Orphan Drugs
March 30, 2006
The FDA wants manufacturers of orphan drugs and devices designated for humanitarian use to make regulatory submissions in an electronic format, according to a draft guidance.